Treatment for asthma

Treatment for asthma. (TY Atid-EDI) Israel’s Teva has bought the rights to complete the development of BD9 – an antibody-based therapy for the treatment of asthma and atopic dermatitis from Israel’s Biolojic Design (see here previously). Biolojic’s AI platform generates antibodies that have predictable functions.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *